10. Cardiovascular Disease and Risk Management: <i>Standards of Care in Diabetes—2023</i>
Nuha A. ElSayed(Brigham and Women's Hospital), Robert A. Gabbay(Harvard University), Marisa E. Hilliard, Mary Lou Perry, Diana Isaacs(Cleveland Clinic), Raveendhara R. Bannuru(Tufts Medical Center), Florence M. Brown, Robert C. Stanton, Sarah K. Lyons, Sandeep R. Das, Priya Prahalad(Stanford Medicine), Mikhail Kosiborod(AstraZeneca (Brazil)), Jane Jeffrie Seley(Unknown), Richard E. Pratley(Translational Research Institute for Metabolism and Diabetes), Grazia Aleppo(Northwestern University), Billy S. Collins, Dennis Bruemmer, Kamlesh Khunti(University of Leicester), Eric L. Johnson, Vanita R. Aroda(Brigham and Women's Hospital), José León, Scott Kahan
Cited by 463
Related Papers
Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association
|Circulation|2019|9.1k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Hypoadiponectinemia in Obesity and Type 2 Diabetes: Close Association with Insulin Resistance and Hyperinsulinemia
|The Journal of Clinical Endocrinology & Metabolism|2001|3.4k
2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis
|Arthritis & Rheumatology|2015|2.8k
2. Classification and Diagnosis of Diabetes:<i>Standards of Care in Diabetes—2023</i>
|Diabetes Care|2022|2.4k